PCG Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Sell
6,112
-30
-0.5% -$6.99K 1.11% 22
2026
Q1
$1.5M Sell
6,142
-230
-4% -$53.6K 1.2% 21
2025
Q4
$1.33M Sell
6,372
-203
-3% -$40.1K 1.06% 22
2025
Q3
$1.22M Sell
6,575
-181
-3% -$31K 0.98% 23
2025
Q2
$1.03M Sell
6,756
-46
-0.7% -$7.07K 0.89% 25
2025
Q1
$1.13M Buy
6,802
+5
+0.1% +$782 1.06% 24
2024
Q4
$983K Buy
+6,797
New +$1.05M 0.86% 25

Other funds holding JNJ

PCG Asset Management's JNJ Position: Q2 2026 in Review

PCG Asset Management reduced its Johnson & Johnson (JNJ) stake by 0.49% in Q2 2026, selling an estimated $6.99K and leaving 6,112 shares worth $1.55M. The position accounts for 1.11% of the portfolio, ranked #22.

PCG Asset Management first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • PCG Asset Management held 6,112 shares of Johnson & Johnson worth $1.55M as of Q2 2026.
  • PCG Asset Management sold 30 Johnson & Johnson shares in Q2 2026, an estimated $6.99K.
  • Johnson & Johnson made up 1.11% of PCG Asset Management's portfolio in Q2 2026, its #22 holding.
  • PCG Asset Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on PCG Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.